Announcements

03APR

Removal of Component(s) – FTSV

4/3/2020 Effective at the market close on Monday, April 6, 2020, FTSV will be removed from the LifeSci Biotechnology Clinical Trials Index and its value will be redistributed to the remaining index components based on their weights. On March 2, 2020, Forty Seven agreed to be acquired by Gilead for $95.50 per share in cash.    
30MAR

Removal of Component(s) – RARX

3/30/2020 Effective at the market close on Wednesday, April 1, 2020, RARX will be removed from the LifeSci Biotechnology Clinical Trials Index and its value will be redistributed to the remaining index components based on their weights. On October 10, 2019, RA Pharmaceuticals agreed to be acquired by UCB for $48 per share in cash.
27JAN

Removal of Component(s) – ACHN

1/27/2020 Effective at the market close on Tuesday, January 28, 2020, ACHN will be removed from the LifeSci Biotechnology Clinical Trials Index and its value will be redistributed to the remaining index components based on their weights. On January 27, 2020, FTC approval was granted for Alexion Pharmaceuticals’ acquisition of Achillion Pharmaceuticals for $6.30/share in cash plus a non-tradeable contingent value right.
12DEC

Index Semi-Annual Reconstitution (Final) - December 2019

Index Semi-Annual Reconstitution (Final) The LifeSci Biotechnology Products Index and the LifeSci Biotechnology Clinical Trials Index will be reconstituted as of the market open on Tuesday, December 17, 2019.  All positions will be equally weighted, with weights determined as of the closing prices on Friday, December 13, 2019.  The preliminary changes, subject to modification, are summarized below. LifeSci Biotechnology Clinical Trials Index Additions (22 stocks): AKRO, ARDX, BBIO, CNST, CRSP, CRTX, CVM, DTIL, FIXX, KDMN, KOD, KRTX, NXTC, ODT, PRVB, RIGL, SWTX, TBIO, TPTX, XBIT, YMAB, ZYME Deletions (20 stocks): ABEO, AIMT, AKCA, ARQL, BGNE, BOLD, CBAY, GBT, GRTS, INSM, KALV, KPTI, LJPC, MGTA, PHAS, PRQR,
09DEC

Index Semi-Annual Reconstitution (Preliminary) - December 2019

Index Semi-Annual Reconstitution (Preliminary) The LifeSci Biotechnology Products Index and the LifeSci Biotechnology Clinical Trials Index will be reconstituted as of the market open on Tuesday, December 17, 2019.  All positions will be equally weighted, with weights determined as of the closing prices on Friday, December 13, 2019.  The preliminary changes, subject to modification, are summarized below. LifeSci Biotechnology Clinical Trials Index Additions (22 stocks): AKRO, ARDX, BBIO, CNST, CRSP, CRTX, CVM, DTIL, FIXX, KDMN, KOD, KRTX, NXTC, ODT, PRVB, RIGL, SWTX, TBIO, TPTX, XBIT, YMAB, ZYME Deletions (20 stocks): ABEO, AIMT, AKCA, ARQL, BGNE, BOLD, CBAY, GBT, GRTS, INSM, KALV, KPTI, LJPC, MGTA, PHAS, PRQR,
18NOV

Removal of Component(s) – CELG

11/18/2019 Effective at the market close on Wednesday, November 20, 2019, CELG will be removed from the LifeSci Biotechnology Products Index and its value will be redistributed to the remaining index components based on their weights. On January 3, 2019, Celgene Corporation (CELG) announced that it will be acquired by Bristol-Myers Squibb Company for $50.00 per share in cash, one share of BMY and one CVR for each share of CELG.
18OCT

Removal of Component(s) – ALDR

LifeSci Biotechnology Clinical Trials Index   Effective at the market close on Monday, October 21, 2019, ALDR will be removed from the LifeSci Biotechnology Clinical Trials Index and its value will be redistributed to the remaining index components based on their weights. On September 16, 2019, Alder BioPharmaceuticals (ALDR) announced that it will be acquired by Biogen Inc. for $18.00 per share in cash along with one non-tradeable contingent value right.  
30JUL

Removal of Component(s) – ARRY

LifeSci Biotechnology Products Index Removal of Component(s) – ARRY 7/30/2019   Today, Pfizer announced that it has closed its previously announced acquisition of Array Biopharma (ARRY).  As a result, effective at the market close on Wednesday, July 31, 2019, the value of ARRY will be removed from the LifeSci Biotechnology Products Index and its value will be redistributed to the remaining index components based on their weights.  
14JUN

Index Semi-Annual Reconstitution (Final) - June 2019

LifeSci Biotechnology Products Index LifeSci Biotechnology Clinical Trials Index   The LifeSci Biotechnology Products Index and the LifeSci Biotechnology Clinical Trials Index will be reconstituted as of the market open on Tuesday, June 18, 2019.  All positions will be equally weighted, with weights determined as of the closing prices on Friday, June 14, 2019.  The preliminary changes, subject to modification, are summarized below.   LifeSci Biotechnology Clinical Trials Index Additions (17 stocks): -   ADVM, ALEC, ALLO, ARVN, AXSM, FTSV, GOSS, GRTS, KALV, KRYS, MGTA, MGTX, MRNA, MYOV, ORTX, PHAS, THOR Deletions (16 stocks): -  ADAP, APTX, ASRT, CRNX, FPRX, INO, KDMN, KNSA, MRKR, NVAX, OPTN, SAGE, SLDB, STIM, STML,
10JUN

Index Semi-Annual Reconstitution (Preliminary) - June 2019

Index Semi-Annual Reconstitution (Preliminary) The LifeSci Biotechnology Products Index and the LifeSci Biotechnology Clinical Trials Index will be reconstituted as of the market open on Tuesday, June 18, 2019.  All positions will be equally weighted, with weights determined as of the closing prices on Friday, June 14, 2019.  The preliminary changes, subject to modification, are summarized below. LifeSci Biotechnology Clinical Trials Index Additions (17 stocks): ADVM, ALEC, ALLO, ARVN, AXSM, FTSV, GOSS, GRTS, KALV, KRYS, MGTA, MGTX, MRNA, MYOV, ORTX, PHAS, THOR Deletions (16 stocks): ADAP, APTX, ASRT, CRNX, FPRX, INO, KDMN, KNSA, MRKR, NVAX, OPTN, SAGE, SLDB, STIM, STML, SVRA Summary: The updated index will have 95 equal-weighted components
03JUN

Removal of Component(s) - NITE

LifeSci Biotechnology Clinical Trials Index Removal of Component(s) – NITE 6/3/2019 Effective at the market close on Thursday, June 6, 2019, NITE will be removed from the LifeSci Biotechnology Clinical Trials Index and its value will be redistributed to the remaining index components based on their weights. On 3/4/2019, Nightstar Therapeutics plc (NITE) announced that it will be acquired by Biogen Inc. for $25.50 per share in cash. 
01APR

Removal of Component(s) - ONCE

LifeSci Biotechnology Products Index Removal of Component(s) – ONCE 4/1/2019 Effective at the market close on Wednesday, April 3, 2019, ONCE will be removed from the LifeSci Biotechnology Products Index and its value will be redistributed to the remaining index components based on their weights. On 2/25/2019, Spark Therapeutics (ONCE) announced that it will be acquired by Roche AG for $114.50 per share in cash. 
13DEC

Index Semi-Annual Reconstitution (Final) - December 2018

The LifeSci Biotechnology Products Index and the LifeSci Biotechnology Clinical Trials Index will be reconstituted as of the market open on Monday, December 17, 2018.  All positions will be equally-weighted, with weights determined as of the closing prices on Thursday, December 13, 2018.   LifeSci Biotechnology Clinical Trials Index Additions (23 stocks): -          ALLK, AMRS, APTX, ASND, ASRT, AUTL, AVRO, CRNX, DRNA, EIDX, KDMN, KNSA, MRKR, NITE, OPTN, PRNB, PRQR, RARX, STIM, SVRA, TCDA, UBX, WVE Deletions (26 stocks): -          ADRO, ADVM, AKAO, ALBO, ALNY, ARRY, AVEO, AXON, BLCM, CBIO, CLSD, ECYT, FOLD, IDRA, LOXO, MLNT, MNOV, MRNS, PIRS, PRTK, RCUS, SELB, SGYP, SYRS, TORC, VSTM Summary: -         
10DEC

Index Semi-Annual Reconstitution (Preliminary) - December 2018

The LifeSci Biotechnology Products Index and the LifeSci Biotechnology Clinical Trials Index will be reconstituted as of the market open on Monday, December 17, 2018.  All positions will be equally-weighted, with weights determined as of the closing prices on Thursday, December 13, 2018.  The preliminary changes, subject to modification, are summarized below. LifeSci Biotechnology Clinical Trials Index Additions (24 stocks):  ALLK, AMRS, APTX, ASND, ASRT, AUTL, AVRO, CRNX, DRNA, EIDX, KDMN, KNSA, MRKR, NITE, OPTN, PRNB, PRQR, RARX, STIM, SVRA, TCDA, TOCA, UBX, WVE Deletions (26 stocks):  ADRO, ADVM, AKAO, ALBO, ALNY, ARRY, AVEO, AXON, BLCM, CBIO, CLSD, ECYT, FOLD, IDRA, LOXO, MLNT,
14JUN

LifeSci Biotechnology Indexes: Semi-Annual Reconstitution (Final)

The LifeSci Biotechnology Products Index and the LifeSci Biotechnology Clinical Trials Index will be reconstituted as of the market open on Monday, June 18, 2018.  All positions will be equally-weighted, with weights determined as of the closing prices on Thursday, June 14, 2018.  (There are no changes to the preliminary index changes announced on June 8, 2018.) LifeSci Biotechnology Clinical Trials Index Additions (27 stocks): ADAP, ADVM, ALBO, APLS, ARQL, ARWR, BHVN, CBIO, CCXI, CLSD, DCPH, DNLI, ECYT, FATE, MNOV, PGNX, RCKT, RCUS, RYTM, SELB, SGYP, SLDB, SRNE, SYRS, TORC, VKTX, VSTM Deletions (11 stocks): AGIO, ARDX, CALA, CLDX, DOVA, JNCE, MCRB, NLNK, RARE, RIGL,